Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Casez

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Revue Neurologique|July 15, 2006
[Abnormal movements of psychogenic origin: usefulness of the readiness potential]O Casez, L Vercueil
Revue Neurologique|March 18, 2017
Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interferenceT Willeman, O Casez, P Faure
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2016
[Lower urinary tract dysfunction in normal pressure hydrocephalus: Review of the literature]E Bey, B Nicot, O Casez, et al.
Revue Neurologique|December 1, 2020
Post-infectious relapsing encephalomyelitis due to toxocara canisL Legris, J Papassin, O Cognet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]C Thuillier, C Overs, J Descotes, et al.
Revue Neurologique|January 9, 2023
Paradigm shifts in multiple sclerosis management: Implications for daily clinical practiceB Bourre, O Casez, J Ciron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosisG Hinsinger, N Galéotti, N Nabholz, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Revue Neurologique|July 15, 2006
[Abnormal movements of psychogenic origin: usefulness of the readiness potential]O Casez, L Vercueil
Revue Neurologique|March 18, 2017
Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interferenceT Willeman, O Casez, P Faure
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2016
[Lower urinary tract dysfunction in normal pressure hydrocephalus: Review of the literature]E Bey, B Nicot, O Casez, et al.
Revue Neurologique|December 1, 2020
Post-infectious relapsing encephalomyelitis due to toxocara canisL Legris, J Papassin, O Cognet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 14, 2015
[Not Available]C Thuillier, C Overs, J Descotes, et al.
Revue Neurologique|January 9, 2023
Paradigm shifts in multiple sclerosis management: Implications for daily clinical practiceB Bourre, O Casez, J Ciron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosisG Hinsinger, N Galéotti, N Nabholz, et al.
European Journal of Neurology|July 31, 2013
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohortO Outteryck, J C Ongagna, B Brochet, et al.
BMC Medical Research Methodology|May 31, 2022
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosisM Lefort, S Sharmin, J B Andersen, et al.
Pageof 1